Clinical trial
Does Therapeutic Plasma Exchange Have A Role in Resistant Cytokine Storm State Of COVID-19 Infection?
NCT04457349 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Therapeutic Plasma Exchange Have A Role in Resistant Cytokine Storm State Of COVID-19 Infection?
- Lead sponsor
- Alexandria University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 25, 2020
- Completion date
- January 20, 2021
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid 19